|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01244 3D MEDICINES
Nominal 
2.150 0.000 (0.000%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (144,413) | (278,779) | (377,079) | (278,329) |
| Net Cash from / (used in) Investing Activities | -- | (187,579) | (242,106) | (98,871) | (20,480) |
| Net Cash from / (used in) Financing Activities | -- | 304,511 | 408,413 | 840,082 | 607,387 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (27,481) | (112,472) | 364,132 | 308,578 |
| Cash & Cash Equivalents at beginning of period | -- | 696,740 | 774,306 | 414,261 | 112,156 |
| Effect of Foreign Exchange Rate Changes | -- | (2,787) | 34,906 | (4,087) | (6,473) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 666,472 | 696,740 | 774,306 | 414,261 |
| Remarks: | Real time quote last updated: 15/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -103,509,000 |
| %Change | -42.007% |
| EPS / (LPS) | RMB -0.420 |
| NBV Per Share (¥) | RMB 3.284 |